World BI’s Drug Discovery Innovation Programme (DDIP) EU 2026 brings together leaders from pharma, biotech, academia, and emerging technology companies to address the most critical challenges in early-stage drug discovery and translational science.
From small molecules and biologics to AI-driven discovery, biomarker development, and novel therapeutic platforms, DDIP is designed to deliver scientific depth, real-world case studies, and future-facing insights that accelerate the journey from idea to impact.
Speakers
Attendees
Networking Hours
Industry Visionaries at DDIP
A Platform of Discovery, Strategy, and Collaboration
Gain insights from leading Pharma, Biotech, and early-phase R&D solution providers redefining how drugs are discovered and developed.
DDIP Europe provides a dedicated platform for emerging biotech companies to present innovative drug discovery solutions to industry leaders, investors, and strategic partners.
How DDIP Europe Works
Secure Your Place
Register online and choose the pass that fits your role perfectly.
Plan your agenda, speakers, and 1:1 meetings to maximize impact.
Personalize Your Experience
Personalize Your Experience
Plan your agenda, speakers, and 1:1 meetings to maximize impact.
Connect Before You Arrive
Engage with attendees, speakers, and solution providers ahead of time.
Join panels, roundtables, pitch sessions, and networking receptions for collaboration.
Learn, Network, Collaborate
Learn, Network, Collaborate
Join panels, roundtables, pitch sessions, and networking receptions for collaboration.
Create Lasting Impact
Each registration supports sustainability and responsible innovation beyond the conference.